Differences by age and race/ethnicity in knowledge about hypercholesterolemia

Robert C. Kaplan, Narendra C. Bhalodkar, David L. Brown, Jessica White, Edward J. Brown

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

This investigation sought to identify gaps in patients' knowledge about hypercholesterolemia and lipid-lowering therapy in an inner-city US population. Chart reviews and interviews were conducted for drug-treated hypercholesterolemic patients at 3 hospital-based cardiology practices in Bronx, NY. Univariate and multivariate analyses were used to assess whether race/ethnicity, sex, and age were predictors of knowledge. Subjects (n = 467, age 65.3 years) were 55% female, 38% Hispanic, 32% black, and 25% white. Most recognized hypercholesterolemia as a cause of heart disease (88%) and stroke (76%), although older subjects (>70 years) and Hispanic subjects, particularly non-English speakers, were significantly less likely to know about cardiovascular disease risks associated with hypercholesterolemia. Only 14% recalled their recent cholesterol levels, and recall was significantly lower among black, Hispanic, and older subjects. Overall, 31% expected to require lipid-lowering medications indefinitely in the future, while 66% did not know how long they would need to continue using medications. Blacks and Hispanics were significantly less likely to believe that they would need to continue taking medications indefinitely. Achieved lipid levels and self-reported medication adherence were relatively favorable although were unrelated to knowledge levels. In summary, among hypercholesterolemic patients in an urban population, relatively few knew their own cholesterol levels or expected to require medications indefinitely in the future. Older patients, black and Hispanic patients, and non-English speakers were significantly less likely to have accurate knowledge about hypercholesterolemia. Therefore, patient and community education efforts targeted to specific populations may lead to improved management of hypercholesterolemia in inner-city regions.

Original languageEnglish (US)
Pages (from-to)1-6
Number of pages6
JournalCardiology in Review
Volume14
Issue number1
DOIs
StatePublished - Jan 2006

Fingerprint

Hypercholesterolemia
Hispanic Americans
Lipids
Cholesterol
Urban Population
Medication Adherence
Patient Education
Cardiology
Population
Heart Diseases
Cardiovascular Diseases
Multivariate Analysis
Stroke
Interviews
Pharmaceutical Preparations
Therapeutics

Keywords

  • Health disparities
  • Hypercholesterolemia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Differences by age and race/ethnicity in knowledge about hypercholesterolemia. / Kaplan, Robert C.; Bhalodkar, Narendra C.; Brown, David L.; White, Jessica; Brown, Edward J.

In: Cardiology in Review, Vol. 14, No. 1, 01.2006, p. 1-6.

Research output: Contribution to journalArticle

Kaplan, Robert C. ; Bhalodkar, Narendra C. ; Brown, David L. ; White, Jessica ; Brown, Edward J. / Differences by age and race/ethnicity in knowledge about hypercholesterolemia. In: Cardiology in Review. 2006 ; Vol. 14, No. 1. pp. 1-6.
@article{ec1dcce1fcfd4a9aafe46a647c51a208,
title = "Differences by age and race/ethnicity in knowledge about hypercholesterolemia",
abstract = "This investigation sought to identify gaps in patients' knowledge about hypercholesterolemia and lipid-lowering therapy in an inner-city US population. Chart reviews and interviews were conducted for drug-treated hypercholesterolemic patients at 3 hospital-based cardiology practices in Bronx, NY. Univariate and multivariate analyses were used to assess whether race/ethnicity, sex, and age were predictors of knowledge. Subjects (n = 467, age 65.3 years) were 55{\%} female, 38{\%} Hispanic, 32{\%} black, and 25{\%} white. Most recognized hypercholesterolemia as a cause of heart disease (88{\%}) and stroke (76{\%}), although older subjects (>70 years) and Hispanic subjects, particularly non-English speakers, were significantly less likely to know about cardiovascular disease risks associated with hypercholesterolemia. Only 14{\%} recalled their recent cholesterol levels, and recall was significantly lower among black, Hispanic, and older subjects. Overall, 31{\%} expected to require lipid-lowering medications indefinitely in the future, while 66{\%} did not know how long they would need to continue using medications. Blacks and Hispanics were significantly less likely to believe that they would need to continue taking medications indefinitely. Achieved lipid levels and self-reported medication adherence were relatively favorable although were unrelated to knowledge levels. In summary, among hypercholesterolemic patients in an urban population, relatively few knew their own cholesterol levels or expected to require medications indefinitely in the future. Older patients, black and Hispanic patients, and non-English speakers were significantly less likely to have accurate knowledge about hypercholesterolemia. Therefore, patient and community education efforts targeted to specific populations may lead to improved management of hypercholesterolemia in inner-city regions.",
keywords = "Health disparities, Hypercholesterolemia",
author = "Kaplan, {Robert C.} and Bhalodkar, {Narendra C.} and Brown, {David L.} and Jessica White and Brown, {Edward J.}",
year = "2006",
month = "1",
doi = "10.1097/01.crd.0000160308.62033.29",
language = "English (US)",
volume = "14",
pages = "1--6",
journal = "Cardiology in Review",
issn = "1061-5377",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Differences by age and race/ethnicity in knowledge about hypercholesterolemia

AU - Kaplan, Robert C.

AU - Bhalodkar, Narendra C.

AU - Brown, David L.

AU - White, Jessica

AU - Brown, Edward J.

PY - 2006/1

Y1 - 2006/1

N2 - This investigation sought to identify gaps in patients' knowledge about hypercholesterolemia and lipid-lowering therapy in an inner-city US population. Chart reviews and interviews were conducted for drug-treated hypercholesterolemic patients at 3 hospital-based cardiology practices in Bronx, NY. Univariate and multivariate analyses were used to assess whether race/ethnicity, sex, and age were predictors of knowledge. Subjects (n = 467, age 65.3 years) were 55% female, 38% Hispanic, 32% black, and 25% white. Most recognized hypercholesterolemia as a cause of heart disease (88%) and stroke (76%), although older subjects (>70 years) and Hispanic subjects, particularly non-English speakers, were significantly less likely to know about cardiovascular disease risks associated with hypercholesterolemia. Only 14% recalled their recent cholesterol levels, and recall was significantly lower among black, Hispanic, and older subjects. Overall, 31% expected to require lipid-lowering medications indefinitely in the future, while 66% did not know how long they would need to continue using medications. Blacks and Hispanics were significantly less likely to believe that they would need to continue taking medications indefinitely. Achieved lipid levels and self-reported medication adherence were relatively favorable although were unrelated to knowledge levels. In summary, among hypercholesterolemic patients in an urban population, relatively few knew their own cholesterol levels or expected to require medications indefinitely in the future. Older patients, black and Hispanic patients, and non-English speakers were significantly less likely to have accurate knowledge about hypercholesterolemia. Therefore, patient and community education efforts targeted to specific populations may lead to improved management of hypercholesterolemia in inner-city regions.

AB - This investigation sought to identify gaps in patients' knowledge about hypercholesterolemia and lipid-lowering therapy in an inner-city US population. Chart reviews and interviews were conducted for drug-treated hypercholesterolemic patients at 3 hospital-based cardiology practices in Bronx, NY. Univariate and multivariate analyses were used to assess whether race/ethnicity, sex, and age were predictors of knowledge. Subjects (n = 467, age 65.3 years) were 55% female, 38% Hispanic, 32% black, and 25% white. Most recognized hypercholesterolemia as a cause of heart disease (88%) and stroke (76%), although older subjects (>70 years) and Hispanic subjects, particularly non-English speakers, were significantly less likely to know about cardiovascular disease risks associated with hypercholesterolemia. Only 14% recalled their recent cholesterol levels, and recall was significantly lower among black, Hispanic, and older subjects. Overall, 31% expected to require lipid-lowering medications indefinitely in the future, while 66% did not know how long they would need to continue using medications. Blacks and Hispanics were significantly less likely to believe that they would need to continue taking medications indefinitely. Achieved lipid levels and self-reported medication adherence were relatively favorable although were unrelated to knowledge levels. In summary, among hypercholesterolemic patients in an urban population, relatively few knew their own cholesterol levels or expected to require medications indefinitely in the future. Older patients, black and Hispanic patients, and non-English speakers were significantly less likely to have accurate knowledge about hypercholesterolemia. Therefore, patient and community education efforts targeted to specific populations may lead to improved management of hypercholesterolemia in inner-city regions.

KW - Health disparities

KW - Hypercholesterolemia

UR - http://www.scopus.com/inward/record.url?scp=33644877655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644877655&partnerID=8YFLogxK

U2 - 10.1097/01.crd.0000160308.62033.29

DO - 10.1097/01.crd.0000160308.62033.29

M3 - Article

C2 - 16371759

AN - SCOPUS:33644877655

VL - 14

SP - 1

EP - 6

JO - Cardiology in Review

JF - Cardiology in Review

SN - 1061-5377

IS - 1

ER -